Novo Nordisk to build North Carolina plant to add 1,000 jobs
CLAYTON, N.C. (AP) — Novo Nordisk, the maker of Ozempic and Wegovy, announced on Monday that it plans to add 1,000 jobs when another company manufacturing plant is built in …
CLAYTON, N.C. (AP) — Novo Nordisk, the maker of Ozempic and Wegovy, announced on Monday that it plans to add 1,000 jobs when another company manufacturing plant is built in …
Health experts are warning the public to consider eight vital factors that could lead to a huge surge in cases of a killer disease. The UK could be set to …
Diabetics have to carefully monitor their blood sugar levels or risk serious problems (Image: Getty) A record 3.6 million people are at high risk of developing diabetes as the nation …
Obesity and changing Western diets are believed to be a factor (Image: Getty) Unhealthy lifestyles, an obesity epidemic and poor gut health are feared to be fuelling a “disturbing” explosion …
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Companies are increasing access to new …
Under a proposed revamp of the body-mass-index (BMI) system, millions of Brits could be classified as obese. The World Health Organisation-endorsed system, which measures a person’s weight in relation to …
Diabetes UK warned people have been bombarded by unhealthy food (Image: Getty) Experts are demanding a “tough love” crackdown on obesity to cure sick note Britain after a report revealed …
A new study has found that almost half of all cancer cases are linked to obesity, proving further how crucial it is so stay in shape. The research was carried out …
Experts are warning high levels of fatty liver disease among young people could signal a public health crisis. Fatty liver disease is normally associated with people in their 50’s and …
Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving investors more confidence to keep owning the world’s most valuable health-care company even after …